PHAR

NASDAQ 已收盘

Pharming Group

12.17 USD
▼-0.31-2.48%
盘后 12.28 +0.90%
2026-11-19
市值
$840.43M
市盈率
41.65
EPS
0.28
股息率
—
52 周区间
9.11 – 21.34
成交量
10.59K
Beta
0.05
目标价
35.70
52W 低 9.1152W 高 21.34
价格走势

公司简介

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kδ inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also dev...